AzTrials
AzTrials

Depression in Type 1 Diabetes MellitussNCT07925164

Prevalence and Factors Associated With Depression Among Children and Adolescents With Type 1 Diabetes Mellituss

An observational study of Depression in Type 1 Diabetes Mellituss, run by Asmaa Abdelnasser Madian.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This is cross sectional study conducted at Sohag University Hospital to assess prevalence and factors associated with depression among children and adolescents with type 1 diabetes mellitus .The investigators will include the children and adolescents from 7 to 16 years who are diagnosed with type 1 diabetes mellitus Read more about this study

Who is it for?
Ages 7 to 16 years
Conditions the study is for
Depression in Type 1 Diabetes Mellituss
What is being tested?
Observation follow-up
How many people
100 participants
Where
No sites listed yet
Study dates
Nov 2026to Feb 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: paediatric patient from 7 to 16 years diagnosed with type 1 diabetes mellitus and have depression who are followed in Paediatric Endocrinology Department ,Sohag University Hospital .

Who may be able to join

  • Adolescents aged 7-16 years . Diagnosed with type 1 diabetes mellitus for at least 6 months . On insulin therapy . Able to understand and complete the questionnaires . Consent from parent/guardian and assent from the adolescent

Who cannot join

  • Adolescents with type 2 diabetes or secondary diabetes
  • Severe cognitive impairment preventing questionnaire completion
  • Acute illness at time of assessment
  • Diagnosed psychiatric disorders prior to T1DM diagnosis.
  • Refusal to participate

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Asmaa Abdelnaser Madian, Resident doctor contact

01090850159

asmaa.abdelnaser@med.sohag.edu.eg

About this study

Official title: Prevalence and Factors Associated With Depression Among Children and Adolescents With Type 1 Diabetes Mellitus :A Cross-sectional Study

This is cross sectional study conducted at Sohag University Hospital to assess prevalence and factors associated with depression among children and adolescents with type 1 diabetes mellitus .The investigators will include the children and adolescents from 7 to 16 years who are diagnosed with type 1 diabetes mellitus

Read the detailed description

This is single-centre cross sectional study conducted and the paediatric endocrinology Department ,Sohag University Hospital ,Egypt study population.Childern and adolescents from 7 to 16 years diagnosed with type 1 diabetes mellitus to assess prevalence and factors associated with depression .Data collection :Demographic data,anthropometric data, clinical assessment,laboratory results ,depression assessment using the Children Depression Inventory (CDI) .Objectives:to assess the prevalence and factors associated with depression among childern and adolescents with type 1 diabetes mellitus .This study does not involve any experimental interventions .All investigators and management will be according to standard hospital protocols

Being tested
Observation follow-up

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observation follow-upOther

    No experimental intervention .Data will be collected from routine clinical care,medical records ,and follow up visits according to standard hospital protocols

Study groups in NCT07925164
Study groupRoleWhat they receive
Children from 7 to 16 years diagnosed depression with type 1 diabetes mellitusChildren and adolescents from 7 to 16 years diagnosed with type 1 diabetes mellitus have depression who are followed at Sohag University Hospital
Receives: Other: Observation follow-up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression in type 1 diabetes mellitus

    Prevalence and factors associated with depression among children and adolescents with type 1 diabetes mellitus at Sohag University Hospital

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2026
  2. Study startNov 2026 (estimated)
  3. Primary completionJan 2027 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07925164
Sponsor's protocol ID
Soh-med-26-9-11MS
Status last verified
Nov 2026
First submitted
29 Oct 2026
Last updated
9 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to patient privacy and data protection policies at Sohag University Hospital

Questions about this trial

What is this clinical trial studying?

An observational study of Depression in Type 1 Diabetes Mellituss, run by Asmaa Abdelnasser Madian.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Asmaa Abdelnaser Madian, Resident doctor (01090850159, asmaa.abdelnaser@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression in type 1 diabetes mellitus (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in